drugset / Trial / NCT02299063

Dexmedetomidine Effect on Mitochondrial Function

NCT02299063 ↗

Phase 4 Unknown 36 enrolled The Hospital for Sick Children
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The investigators hypothesize that in addition to a known sympatholytic effect, intraoperative dexmedetomidine reduces adverse changes in mitochondrial function and structure attenuating ischaemia-reperfusion and end-organ injury for children with non cyanotic congenital heart defects having corrective heart surgery.

Timeline

Start
2014-11
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.6 ug/kg Intravenous

Indications